← Back to Search

Play Serious Games with a Social Robot (Ryan) for Alzheimer's Disease

N/A
Waitlist Available
Research Sponsored by DreamFace Technologies, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, and 1 year
Awards & highlights

Study Summary

This trial will study the effects of social interaction on cognitive decline in seniors with Alzheimer's.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in cognitive/memory ability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active GroupExperimental Treatment1 Intervention
Active Group: Group 1 users will play games with and administered by Ryan, 2-3 times a week and 30-minutes per day.
Group II: Control GroupActive Control1 Intervention
Control Group: Group 2 users will play solitary games (word puzzles) and activities but will have no interaction with Ryan.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Play Serious Games with a Social Robot (Ryan)
2020
N/A
~30

Find a Location

Who is running the clinical trial?

DreamFace Technologies, LLCLead Sponsor
2 Previous Clinical Trials
24 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,641 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025